Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells

• Published in: Stem cell research & therapy 2024-09, Vol.15 (1), p.302-15, Article 302
• Main Authors: Raaijmakers, Renée H L, Ausems, C Rosanne M, Willemse, Marieke, Cumming, Sarah A, van Engelen, Baziel G M, Monckton, Darren G, van Bokhoven, Hans, Wansink, Derick G
• Format: Article
• Language: English
• Subjects: Adult; Cell Differentiation; Cell Fusion; Cells, Cultured; Coculture Techniques; Female; Health aspects; Humans; Male; Medical research; Medicine, Experimental; Middle Aged; Muscle Development; Muscle Fibers, Skeletal - metabolism; Muscles; Myoblasts - cytology; Myoblasts - metabolism; Myotonic dystrophy; Myotonic Dystrophy - genetics; Myotonic Dystrophy - metabolism; Myotonic Dystrophy - pathology; Myotonic Dystrophy - therapy; Myotonin-Protein Kinase - genetics; Myotonin-Protein Kinase - metabolism; Pericytes - metabolism; RNA; Scientific equipment and supplies industry; Stem cells
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-024-03913-y

Cell-based strategies are being explored as a therapeutic option for muscular dystrophies, using a variety of cell types from different origin and with different characteristics. Primary pericytes are multifunctional cells found in the capillary bed that exhibit stem cell-like and myogenic regenerative properties. This unique combination allows them to be applied systemically, presenting a promising opportunity for body-wide muscle regeneration. We previously reported the successful isolation of ALP pericytes from skeletal muscle of patients with myotonic dystrophy type 1 (DM1). These pericytes maintained normal growth parameters and myogenic characteristics in vitro despite the presence of nuclear (CUG) RNA foci, the cellular hallmark of DM1. Here, we examined the behaviour of DM1 pericytes during myogenic differentiation. DMPK (CTG) repeat lengths in patient pericytes were assessed using small pool PCR, to be able to relate variation in myogenic properties and disease hallmarks to repeat expansion. Pericytes from unaffected controls and DM1 patients were cultured under differentiating conditions in vitro. In addition, the pericytes were grown in co-cultures with myoblasts to examine their regenerative capacity by forming hybrid myotubes. Finally, the effect of pericyte fusion on DM1 disease hallmarks was investigated. Small pool PCR analysis revealed the presence of somatic mosaicism in pericyte cell pools. Upon differentiation to myotubes, DMPK expression was upregulated, leading to an increase in nuclear foci sequestering MBNL1 protein. Remarkably, despite the manifestation of these disease biomarkers, patient-derived pericytes demonstrated myogenic potential in co-culture experiments comparable to unaffected pericytes and myoblasts. However, only the unaffected pericytes improved the disease hallmarks in hybrid myotubes. From 20% onwards, the fraction of unaffected nuclei in myotubes positively correlated with a reduction of the number of RNA foci and an increase in the amount of free MBNL1. Fusion of only a limited number of unaffected myogenic precursors to DM1 myotubes already ameliorates cellular disease hallmarks, offering promise for the development of cell transplantation strategies to lower disease burden.